Delivery Order SPE2DB20D7059-SPE2DB25FGTM5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mresvia 50 mcg/0.5 mL syringes with a ceiling value of $29,841.60. The delivery order is structured as a firm fixed price contract with an ultimate completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting the contractor's proven capability to...
- The Defense Logistics Agency (DLA) awarded a $1,492.08 delivery order to AmerisourceBergen Drug Corp for Mresvia 50 micrograms/0.5 milliliter syringes on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,344.46 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Aranest 40 MCG/0.4 ML syringes. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on September 18, 2025, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. This...
- The Defense Logistics Agency has awarded a $6,210.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 3 mL syringes. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, will be performed in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle designated SPE2DX and...
- The Defense Logistics Agency awarded a $6,289.56 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Provision 10 mg/mL disposable syringes in 0.55 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vimkunya 40 mcg/0.8 mL syringes with a ceiling value of $5,619.60. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively issued. The contract is scheduled for completion by September 9, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,096.82 to AmerisourceBergen Drug Corp for the provision of 10 mg/ml disposable syringes in 0.55ml quantities. The contract employs firm fixed pricing and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,422.99 to AmerisourceBergen Drug Corp for Araneps 200 mcg/0.4 ml syringes on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price contract represents a non-compete award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.66 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Elucirem 5 mmol/10 ml syringes. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGTM5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mresvia 50 mcg/0.5 mL syringes with a ceiling value of $14,920.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action under a larger federal contract vehicle supporting the military medical supply chain. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that supplies an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards, with its contract portfolio spanning multiple therapeutic domains and delivery formats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 9/26/25 |